PQE launches the new Digital Governance Business Line
At PQE Group we foster innovation, efficiency and quality services for sustainable regulated compliance solutions.
List view / Grid view
At PQE Group we foster innovation, efficiency and quality services for sustainable regulated compliance solutions.
The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting.
Decreased supply of anti-rabies vaccines (ARVs) in Delhi causes outbreak of the disease.
Building from the company’s best-selling SCIEX Triple Quad™ for over 10 years, users can now get triple quad sensitivity plus QTRAP® functionality in one system.
New supercomputing centres have been selected to support Europe's researchers, industry and businesses to design medicines.
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.